Pay in installments of $6.83 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 16 - Oct 21
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
A Cost That's Hard to (G)u(LP 1) Down Paragon Health Institute Eriocitrin: A review of pharmacological effects ScienceDirect Designing fiscally viable coverage of GLP 1 weight loss drugs #AD Do you want my honest review of GLP 1 medications as a dietitian? , , Here it is:, , These medications can be a terrific tool in combination with lifestyle change to promote lasting weight Can You Use HSA FSA Funds for GLP 1 Medications GLP Winner
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.7 ★★★★★
Based on 13 reviews
Sort
Product Reviews
★★★★★ 5
proper documentation from langchain
Format: Paperback
Liked the book. But Still missing Human in the loop.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 19, 2025
★★★★★ 3
Already outdated
Format: Paperback
Concepts are sound but the code in this book is already obsolete
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on August 5, 2025
★★★★★ 5
Unlocking Practical AI: A Developer’s Guide to Building with LLMs and LangChain
Format: Paperback
If you're a developer eager to move beyond LLM experimentation and build robust, context-aware AI applications, this book offers both inspiration and practical guidance. The authors open with a clear passion for the transformative potential of large language models (LLMs) and LangChain, framing these technologies as not just enhancements to the developer’s toolkit, but as gateways to new kinds of “thing-building” superpowers. This sense of possibility is grounded in step-by-step instruction, making the book approachable for those with Python or JavaScript backgrounds who may be new to the world of production-grade AI agents.
What stands out is the book’s careful scaffolding: starting with foundational concepts like prompt-based programming and progressing to advanced capabilities such as retrieval-augmented generation, agent planning, and tool integration. Each stage is contextualized with real-world use cases, like customizing chatbots to interact with your own documents, personalizing user experiences through memory, and deploying to production with reliability and security in mind. The focus on chain-of-thought reasoning and LangGraph’s agent architecture demonstrates the authors’ awareness of the current state of AI, where context and planning are just as important as raw language ability.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on July 17, 2025
★★★★★ 5
Excellent Handbook
Format: Paperback
What got my interest in this book is the author. He's well-known as a leader in the LangChain world. And his book did not disappoint. It goes through the whole life cycle of development and there is a lot useful insights. If you are looking to build real-world genAI/agentic apps, then this book is certainly a great choice.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 11, 2025
★★★★★ 5
Useful resource!
Format: Paperback
I found this book well written and extremely useful for getting comfortable with LLMs for building AI apps in production and other agent driven applications.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 10, 2025
recommand products
GLP-1 Sales Online: What You Need to Know
21.04
🎙️ NEW EPISODE: Retatrutide—The Triple Agonist *Not licensed* Will this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in
24.62
Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. @adamyamaguchi
22.91
Semaglutide Prescription Rates
22.81
Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation
27.64